Podcasts about zebra medical vision

Starting a career in the Israeli army, becoming a lawyer, and finally transforming the field of medical imaging. In a very schematic way, this is what might define Ohad Arazi's path, who is now spearheading the field of handheld ultrasound as the CEO of Clarius. His curiosity for medical imaging - coupled with a very product-oriented mindset and an unrelenting desire to understand the problems that healthcare faces - leads him to integrate different structures, including the Fortune 500 giant McKesson, the Canadian telecommunication company Telus, and the Israeli startup Zebra Medical Vision, where he quickly occupies leadership roles with great responsibility. At Clarius (this “true gem” as he calls it in his own words) he draws on his expertise in the field of medical imaging to embed artificial intelligence into the most compact high quality ultrasound imaging platform on the market, developed by its brilliant founder Laurent Pelissier. The goal? Allowing any healthcare professional to perform an ultrasound scan, with a system as intuitive, qualitative, and compact as an iPhone. Perhaps those will even find their place in patient's homes at some point! In light of the current boom in digital health and the radical developments in AI, Ohad shares his perspective on the role that these technologies will have on certain medical specialities and notably radiology, where he believes that they will rather augment them without replacing them. He also explains why he thinks that most technological capabilities in digital health are outstripping the value they can create, and reflects on his career path where his transitions from huge corporates to human-sized startups shaped his evolution and leadership. A surprising dive into the future of medical imaging, that we invite you to discover in this new episode! Timeline: 02:23 - Ohad's background, from the military in Israel to healthcare in Canada 10:46 - What the medical imaging landscape looked like in the early 2000s 14:51 - Ohad's take on the current boom in digital health 19:36 - Clarius' mission in transforming high-end ultrasound for healthcare professionals 33:11 - How AI is embedded into the products from Clarius 35:09 - Dealing with hypergrowth as a medical imaging startup 39:48 - Ohad's reflections on his career path and the story of the Disney brothers What we also talked about with Ohad: OpenAI Turtle Health US2.ai PACS DICOM EHR James Hare Carolyn Lam We cited with Ohad some of the past episodes from the series: #1 - Measuring your arterial age to prevent heart diseases - Ted Baldwin - Imageens #12 - Unleashing the power of digital health - Daniel Kraft - Digital.Health As mentioned in the episode, you can learn more about Clarius through their website and follow their activities on LinkedIn, Twitter, Facebook, Instagram and YouTube! If you want to get in touch with Ohad, feel free to contact him per email at ohad.arazi@clarius.com or through LinkedIn. If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or per email at mathieu@impulsepodcast.com. And if you liked the episode, don't hesitate to share it, subscribe to the podcast and leave a positive review on streaming platforms! Finally, you can follow our activities through our website, over LinkedIn, Twitter or on Instagram!

In this episode, I speak with Assaf Pinhasi, ML engineering and MLOps consultant extraordinaire! Assaf was the VP R&D at Zebra Medical Vision, and built the PayPal Risk organization's Big Data Platform. We dive into building ML infrastructure from scratch 10 years ago vs. today, best practices involved in building teams to support machine learning models in production, and the future of generative models. Watch the video: https://youtu.be/tSbuDA5tMxQ Join our Discord community: https://discord.gg/tEYvqxwhah ➡️ Assaf Pinhasi on LinkedIn – https://www.linkedin.com/in/assafpinhasi/

Prior to COVID-19, digital transformation projects were at a pace of their own - slow and experimental. For the fifth installment of SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, leading digital health startups provide a unique view into the revolution in artificial intelligence and how it's shaping MedTech trends, and where investment opportunity lies. Hear from Zebra Medical providing automated, accurate AI imaging diagnosis, Diagnostic Robotics's AI triage and clinical-predictions platform, and BrainQ, developing an AI-powered electromagnetic field therapy to reduce neuro disorders related disabilities. Featuring Ohad Arazi, Chief Executive Officer of Zebra Medical Vision, Maya Orlicky, Vice President, Strategy of Diagnostic Robotics, and Yotam Drechsler, Chief Executive Officer of BrainQ. ————————————————————————— To learn more about this episode, including podcast transcripts and show notes, visit *salt.org/talks* ( http://salt.org/talks ) Moderated by Anthony Scaramucci.

We chat with Iddo from his Tel Aviv apartment about his experience with startups in Germany and Israel, cultural differences, and how he leads product at Zebra. Iddo focuses the conversation on human-AI collaboration which is at the core of the work he does at Zebra. Notably he discusses how he brings value to clients with different market dynamics in the US, the UK, and Germany.

Tomer is a Partner & CFO at aMoon, where he leads mid-late stage investments in healthtech companies. Tomer joined aMoon in early 2018 and led several investments including $30M Series C round in Zebra Medical Vision and $55M Series D round in Seer. He is also a board member in PharmaTwoB and Mapi. With 15 years of US capital markets experience, Tomer spearheads aMoon's Bridge to Wall Street, where he manages the fund's relationships with major investment banks, equity research analysts and investment funds. Prior to joining aMoon, Tomer was the CFO & COO of Alcobra, a NASDAQ-listed development-stage biotech company, where he led successful public equity offerings from leading US healthcare funds. Prior to joining Alcobra, he was an Executive Director in J.P. Morgan's Investment Banking Division in New York, where he played a leading role in numerous capital market and mergers and acquisitions transactions. In this capacity, he advised senior management and boards of directors of J.P. Morgan's key U.S. clients, including several S&P 500 healthcare firms. Prior to joining J.P. Morgan, Tomer worked in Citigroup's Investment Bank in New York. From 2000 to 2003, he served as an economist in the Financial Advisory Unit to the Chief of Staff of the Israel Defense Forces. Tomer holds a Ph.D. in Finance and Economics (with Distinction) from Columbia Business School and has published a number of corporate finance articles in leading academic and practitioner journals. He also holds an M.Sc. in Finance and Accounting (Magna Cum Laude) and a B.A. in Economics and Management (Magna Cum Laude), both from Tel-Aviv University. https://www.linkedin.com/in/tomerberkovitz/ | https://www.amoon.fund/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

AI Eye Episode 385: Oracle (NYSE: $ORCL) Makes Autonomous Database Available in Customer Data Centers and TELUS (TSX: $T.TO) Ventures Enters Strategic Agreement with Zebra Medical Vision

AI Eye Episode 385: Oracle (NYSE: $ORCL) Makes Autonomous Database Available in Customer Data Centers and TELUS (TSX: $T.TO) Ventures Enters Strategic Agreement with Zebra Medical Vision

The workload for radiologists has reached the point that it is impossible to keep up with demand. AI based technologies may be able to support new clinical workflows, improve automation, and ensure that physicians are focused on the cases that are most in need of their attention. Eyal Gura speaks on how he co-founded and built Zebra Medical Vision, one of the leading organizations poised to revolutionize radiology using AI.

Under the DataScope is a six-episode podcast series from the Kraft Precision Medicine Accelerator at Harvard Business School, showcasing the most important companies that bring data & analytics technologies to precision medicine today. You’ll hear from Professors Richard Hamermesh and Kathy Guisti, plus leaders in the field, including John Wilbanks of Sage Bionetworks, David Shaywitz of Takeda Ventures, Jeff Elton from Concerto Health AI, Wout Brusselaers, Founder & CEO of Deep6, Richard Williams of Wuxi NextCode, and Eyal Gura, Founder & CEO, Zebra Medical Vision. Hosted by Gabriel Eichler.

Israeli victims on flight ET-302 identified The two Israeli victims killed aboard Ethiopian airlines flight ET-302 over Addis Ababa identified as 49-year-old Avraham Matzliah and 58-year-old Shimon Re'em Bitton a civic defense contractor and chief of security in two Israeli Embassies in South America. 2. Graham vows to push for Golan recognition United States Senator Lindsey Graham agreed to help pressure the United States into recognizing Israeli sovereignty over the Golan Heights. Sen. Graham vows to push for Golan recognition Hezi Kugler, Democrats Abroad Israel Media Spokesperson and Dr. Martin Sherman, Founder & Executive Director of the IISS join us in the studio to speak about Senator Graham's decision to help pressure the United States into recognizing Israeli sovereignty over the Golan Heights. 4.Police arrest top members of ‘Telegrass' network A month's long covert operation has now just culminated, with the arrest of 42 suspected drug traffickers, and the seizure of hundreds of millions of shekels of the drug-dealing Telegrass network; which operated through the telegram messaging app. 5.Palestinian tries to stab soldiers in Hebron A Palestinian terrorist attempted to stab Israeli soldiers in the West Bank city of Hebron. No Israeli servicemen were injured in the attack, and the IDF responded with live fire, killing the suspect. PM Netanyahu's hearing is set for July 10 Attorney General Avichai Mandelblit on Monday announced that the investigatory materials against the Prime Minister would indeed be withheld from prosecutors until after April elections. 7.Olim get a taste of the upcoming elections ILTV'S Joy Gavillon joins us in the studio to speak about the group ‘Bogrim Haaretz' from the ‘World Bnei Akiva' organization that held an elections conference completely in English with a special panel that featured leaders from the main parties running in this year's elections. Wonder Woman defends Rotem Sela in new post Gal Gadot is now getting involved in Israel's elections came to the defense of her long-time friend, Israeli TV personality Rotem Sela. After Sela drew the ire of PM Netanyahu and Culture Minister Miri Regev; for criticizing their rhetoric against Israeli Arabs. ‘Zebra Medical Vision' receives massive grant Israel's “Zebra Medical Vision” is a kibbutz-based startup that aims to provide radiologists with the best quality tools for imaging and scan analysis using AI. 10. Israel joins Google's “Once Upon A Try” project Israel's National Library has just announced this month, that it has become the first Israeli organization to contribute to Google's “Once Upon A Try” project. Hebrew word of the Day: Learn a New Hebrew word every day. Today's word is 'NISSAYON' which means ‘AN ATTEMPT, OR EXPERIENCE'. See omnystudio.com/listener for privacy information.

In this episode, I focus on an industry at which Israel leads the world, HealthTech. In a matter of years, Israel's digital health industry has evolved from a small group of innovative start-ups to a rich eco-system around Tel Aviv. In a partnership of private and public sector investment, Israel's HealthTech industry is training AI algorithms, using massive data based on twenty years of medical records from half of Israel's population. This was presented at the third UK Israel Business HealthTech Forum at which I spoke to UKIB's Hugo Bieber, Clalit's Professor Ran Balicer and Eyal Gura of Zebra Medical Vision. Israel has the equivalent of four NHS’s serving its population with a top-up private sector with additional benefits. So what can Israel teach the UK about public healthcare provision? This is a good news story from the start-up nation! Jonny makes these podcasts for free and you can help support him at https://www.paypal.com/cgi-bin/webscr?cmd=_donations&business=BW4GZLQCCL29Y&item_name=Podcast+production+¤cy_code=GBP&source=url

When it comes to finding patterns in huge quantities of data, computers are way better than the human brain--at least once they're properly trained. (This is the hard part.) Zebra Medical Vision is training computers "how to detect malignant tissues in breast mammograms, how to detect brain bleed in head CTs, how to detect vertebral fractures in chest and abdomen CTs, and how to detect opacities and congestive heart failure in chest x-rays and many others." Because not only are computers better at this than people--they can handle the huge quantities of data, as we do more and more scans to diagnose disease. See acast.com/privacy for privacy and opt-out information.

Our guest today, Elad Benjamin, joins the podcast from Israel for the second episode in our series on innovation and the use of AI in healthcare. Elad is CEO and Co-Founder of Zebra Medical Vision and is a veteran Healthcare IT executive with over 20 years of experience in software and medical devices, in both startups and Fortune 500 companies. He has held senior roles in Healthcare IT companies, including playing key roles in taking companies public on the NASDAQ as well as managing complex global businesses implementing solutions in medical providers worldwide. Elad holds a BsC from Tel Aviv University and earned his MBA from the Stanford Graduate School of Business. In 2014, Elad co-founded Zebra Medical Vision, an automated medical imaging diagnostic engine featuring a vast database and using machine learning to create diagnostic insights that will help physicians be more effective in treating their patients. To date, Zebra Medical Vision has raised over $20 million in venture funding from top tier firms including Khosla ventures, SalesForce co-founder Marc Benihoff, and Intermountain Healthcare.   In this episode, Chuck and Elad discuss: Elad’s background and how he initially got into healthcare and healthcare technology Where the idea for Zebra Medical Vision came from The biggest lessons Elad has learned from running his first company to now being at the helm of Zebra Medical How Zebra Medical ensures the AI within the platform only learns from the best data and gets smarter over time while staying uncorrupted How fast Elad believes the use of AI is moving in healthcare and how far he thinks we are from something truly industry/world changing How Elad earned investments from some of the world’s most well known venture capital firms The importance of the makeup of the Zebra Medical Board and what Elad  looks for from a board member with such a technical business Connect with Elad: LinkedIn Twitter Connect with Zebra Medical Vision: Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn

Our guest today, Kevin Freedman, joins me to talk about innovation and the use of AI in healthcare. Kevin is founder of NextPhase Partners, a firm providing independent support and guidance to entrepreneurs as they guide their companies through their next phases of growth. Prior to NextPhase, Kevin was an operating partner at Khosla Ventures and has more than 15 years of operating experience with leadership roles in both consumer and enterprise technology companies. Before joining Khosla Ventures, Kevin was the CEO of Quid, a leading SaaS business intelligence platform, which Fortune 500 companies from Intel and McKinsey to Samsung and Barclays, among others, utilize to better understand the web’s unstructured data. Prior to Quid, he was an early executive at Slide, and took on the role of CFO where he built out the company’s business functions as they scaled to 150 million monthly users and ultimately drove the acquisition by Google. Earlier in his career, Kevin held a variety of senior operating roles at eBay and PayPal, with his initial success in Silicon Valley beginning with Half.com, which was acquired by eBay in 2000. In this episode, Chuck and Kevin discuss: Kevin’s background, and the path that led him into the world of startups and venture capital What are the roles and responsibilities of an “operating partner” How the investment in Zebra Medical Vision came to be and what got Kevin interested in taking a board seat The impact that Kevin thinks AI will play in Healthcare moving forward Connect with Kevin LinkedIn Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn